Zobrazeno 1 - 10
of 420
pro vyhledávání: '"rubella-containing vaccines"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hester E. de Melker, Irene K. Veldhuijzen, Jossy Van den Boogaard, Priscila de Oliveira Bressane Lima, Shalini Desai, Susan Hahné, Brechje de Gier
Background Rubella containing vaccines (RCV) prevent rubella virus infection and subsequent congenital rubella syndrome (CRS). To update the evidence on immunogenicity, duration of protection, effectiveness and safety of RCV, we conducted a systemati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d18b842791ee58d382cc3460b1fce7c
http://hdl.handle.net/10029/624673
http://hdl.handle.net/10029/624673
Publikováno v:
Vaccine. 37:5323-5331
Measles and mumps outbreaks still occur in countries that have successfully implemented universal routine immunization programs. Measles outbreaks are mostly associated to absent or incomplete vaccination, whereas for mumps outbreaks the combined eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99970ed586b5ee5ff5ab27108ce54bb
https://doi.org/10.1016/j.vaccine.2019.07.049
https://doi.org/10.1016/j.vaccine.2019.07.049
Autor:
N. V. Motaze, L. Makhathini, S. B. Smit, C. G. Adu-Gyamfi, M. Fortuin, C. S. Wiysonge, S. M. Suchard
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2656-2662 (2020)
Introduction: South Africa is yet to introduce rubella-containing vaccines (RCV) into its routine immunization schedule. Selecting the target population when introducing RCV should take into account the ages of susceptible individuals in the populati
Externí odkaz:
https://doaj.org/article/a7aafdaf2cc544ec9aa393419b3879ab
Autor:
Nkengafac Villyen Motaze, Zinhle E. Mthombothi, Olatunji Adetokunboh, C. Marijn Hazelbag, Enrique M. Saldarriaga, Lawrence Mbuagbaw, Charles Shey Wiysonge
Publikováno v:
Vaccines, Vol 9, Iss 2, p 84 (2021)
Introduction: Rubella vaccines have been used to prevent rubella and congenital rubella syndrome (CRS) in several World Health Organization (WHO) regions. Mathematical modelling studies have simulated introduction of rubella-containing vaccines (RCVs
Externí odkaz:
https://doaj.org/article/32fdf7fe8c5d471fad73477cc052a637
Autor:
Masresha, Balcha G., Wiysonge, Charles Shey, Katsande, Reggis, O'Connor, Patrick Michael, Lebo, Emmaculate, Perry, Robert T.
Publikováno v:
Vaccines; Aug2024, Vol. 12 Issue 8, p949, 14p
Autor:
Zhuo, Yaning, Lu, Zhaojun, Zhang, Xuechao, Zhang, Xiaoping, Yang, Yingying, Han, Jiayin, Du, Jian, Xu, Yuyang, Liu, Yan, Fu, Chuanxi
Publikováno v:
Frontiers in Immunology; 2024, p1-12, 12p
Autor:
Nkengafac Villyen Motaze, M. Fortuin, C. G. Adu-Gyamfi, Sheilagh B. Smit, Lillian Makhathini, S. M. Suchard, Charles Shey Wiysonge
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction: South Africa is yet to introduce rubella-containing vaccines (RCV) into its routine immunization schedule. Selecting the target population when introducing RCV should take into account the ages of susceptible individuals in the populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c259452adf7a6337beb32002a3fd83ed
https://doi.org/10.1080/21645515.2020.1738834
https://doi.org/10.1080/21645515.2020.1738834